CDKN2A and melanoma: In canine malignant melanoma and melanocytoma, abnormalities of tumor suppressor expression or localization affecting p16, PTEN, p53, Rb and p21 have been noted, but explicit causal associations with malignant progression are yet to be demonstrated (28) [LOE 4b, OEG A].